 DESINGS: We performed a randomised, comparative and open clinical assay carried out in 316 HIV-infected patients. The patients were randomly assigned to one of three regimens, 108 to isoniazid for six months 6H, 103 to rifampin and isoniazid for three months 3RH, and 105 to pyrazinamide and rifampin for two months 2RZ. 